Submission of Investor Presentation for the Quarter and Year ended on March 31 2026
SHAILY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shaily Engineering Plastics reported strong FY26 results with consolidated revenue up 26% YoY to Rs. 990.7 Cr and EBITDA margins expanding 630 bps to 29%. PAT surged 83% to Rs. 169.9 Cr. Healthcare was the standout segment, growing 139% to Rs. 392.8 Cr driven by GLP-1 pen injector contracts including a Rs. 423 Cr four-year order from a large domestic pharma company. Consumer segment declined 9% due to weak European/US home furnishings demand. The company also entered the semiconductor supply chain via a Korean partnership and has an enabling resolution approved for raising up to Rs. 500 Cr through equity or convertible instruments.
The strong margin expansion and healthcare momentum are positive signals. The Rs. 423 Cr order and semiconductor entry broaden the growth narrative, but the enabling resolution for Rs. 500 Cr fund raise could dilute existing shareholders if executed.